Igarashi, K., Kawaguchi, K., Murakami, T., Kiyuna, T., Miyake, K., Yamamoto, N., . . . Hoffman, R. M. (2017). A novel anionic-phosphate-platinum complex effectively targets an undifferentiated pleomorphic sarcoma better than cisplatinum and doxorubicin in a patient-derived orthotopic xenograft (PDOX). Oncotarget.
Chicago Style CitationIgarashi, Kentaro, et al. "A Novel Anionic-phosphate-platinum Complex Effectively Targets an Undifferentiated Pleomorphic Sarcoma Better Than Cisplatinum and Doxorubicin in a Patient-derived Orthotopic Xenograft (PDOX)." Oncotarget 2017.
Cita MLAIgarashi, Kentaro, et al. "A Novel Anionic-phosphate-platinum Complex Effectively Targets an Undifferentiated Pleomorphic Sarcoma Better Than Cisplatinum and Doxorubicin in a Patient-derived Orthotopic Xenograft (PDOX)." Oncotarget 2017.